Randomized, double-blind, controlled trial of preventive inhalation of hypertonic saline in infants with CF (PRESIS) Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018
A randomised controlled trial on the effect of inhaled hypertonic saline on quality of life in primary ciliary dyskinesia Source: Eur Respir J , 49 (2) 1601770; DOI: 10.1183/13993003.01770-2016 Year: 2017
The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial Source: Eur Respir J 2014; 44: 913-921 Year: 2014
Eszopiclone improves the quality of polysomnography: prospective, blinded, placebo-controlled trial Source: Annual Congress 2008 - Assessment of sleep apnoea Year: 2008
A multicenter, randomized, double-blind, double-dummy, 2-way crossover, single dose study, comparing the efficacy and safety of the fluticasone/salmeterol (500/50 μg) combination administered with the new Elpenhaler inhalation device versus the innovative one in patients with asthma Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009
Short-term effect of a single dose of inhaled procaterol on exercise performance in COPD: a randomized, double blind, placebo-controlled, crossover trial Source: Annual Congress 2008 - Physiological response to exercise performance Year: 2008
Glycopyrrolate MDI demonstrates comparable efficacy and safety to tiotropium DPI in a randomized, double-blind, placebo-controlled phase 2b study in patients with COPD Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011
Efficacy and safety of revefenacin (REV), a long-acting muscarinic antagonist for nebulization: results of replicate randomized, double-blind, placebo-controlled, parallel-group phase 3 trials in participants with moderate to very severe COPD Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017
A single centre, double blind, double dummy, placebo controlled, randomized, three period cross-over phase III trial to demonstrate therapeutic equivalence between a generic and branded inhalation product of ipratropium bromide in subjects with Source: Eur Respir J 2001; 18: Suppl. 33, 71s Year: 2001
Inhaled racemic adrenalin versus saline in acute bronchiolitis, a multicenter randomized double-blind clinical trial Source: Annual Congress 2012 - New insights into respiratory infections in children Year: 2012
Clinical effect on asthma control using a novel digital self-management solution: a physician blinded randomized controlled crossover trial Source: International Congress 2019 – Medical education to improve practice Year: 2019
Randomized, double blind, double dummy, placebo-controlled trial designed for comparing the effectiveness of formoterol (Foradil®) Aerolizer® and ipatropium bromide plus nebulized fenoterol (Berodual®) in asthma patients with ages ranging between 5 and 12 years who suffer acute asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010
A double-blind trial of hyperosmolar saline as an adjunt to phsiotherapy in patients with bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 484s Year: 2001
Quality of life in patients with COPD and nocturnal supplemental oxygen-therapy: a prospective, placebo-controlled cross-over trial Source: Eur Respir J 2005; 26: Suppl. 49, 289s Year: 2005
Effect of salmetrol-fluticason combination and tiotropium on clinical and physiological improvement of bronchial anthracofibrosis, a double blind randomized, cross over, placebo controlled, clinical trial. Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017
Late Breaking Abstract - The impact of regular bisoprolol on recovery with salbutamol in asthma; a double-blind randomised controlled trial Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019
A double-blind double dummy randomised placebo-controlled cross-over design clinical trial of formoterol delivered by two different dry powder devices in prevention of bronchoconstriction induced by methacholine in mild to moderate persistent asthma in adult patients Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009
A randomised, placebo-controlled trial of inhaled mannitol in patients with bronchiectasis Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008
A randomized crossover study of sputum induction by physiotherapy and hypertonic saline techniques in asthmatic children Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma Year: 2017